Following a launch to the military medical market in July, a next-generation wound dressing with hemostatic and antibacterial properties is set to be available to the acute care market in early fall. The product, ChitoGauze, comes from Portland-based HemCon Medical Technologies Inc., which previously released two other bandage products that incorporate chitosan, a biopolymer material derived from a substance found in the shells of shrimp that the company says has natural hemostatic properties.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?